Your Source for Venture Capital and Private Equity Financings

Cedilla Therapeutics Inks $82.6M Series B

2021-10-25
CAMBRIDGE, MA, Cedilla Therapeutics has raised $82.6 million in Series B.
Cedilla Therapeutics, a precision oncology biotechnology company, has raised an additional $25 million in an expansion of its Series B financing, bringing the total amount raised to $82.6 million.

The oversubscribed Series B expansion includes new investors RA Capital Management, Janus Henderson Investors, Woodline Partners LP and Logos Capital, along with participation from existing investor Third Rock Ventures.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors